Literature DB >> 15073094

Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications.

Mujib Rahman1, Hiroshi Miyamoto, Chawnshang Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15073094     DOI： 10.1158/1078-0432.ccr-0746-3

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  30 in total

1.  Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors.

Authors:  Chihiro Akimoto; Takashi Ueda; Kazuki Inoue; Ikuko Yamaoka; Matomo Sakari; Wataru Obara; Tomoaki Fujioka; Akira Nagahara; Norio Nonomura; Syuichi Tsutsumi; Hiroyuki Aburatani; Tsuneharu Miki; Takahiro Matsumoto; Hirochika Kitagawa; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

2.  Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity.

Authors:  Hitoshi Ishiguro; Koji Izumi; Eiji Kashiwagi; Yichun Zheng; Yi Li; Takashi Kawahara; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.

Authors:  Hao Wang; Jiang Li; Yang Gao; Ying Xu; Ying Pan; Ichiro Tsuji; Zi-Jie Sun; Xiao-Meng Li
Journal:  Asian J Androl       Date:  2010-05-03       Impact factor: 3.285

4.  Research resource: EPSLiM: ensemble predictor for short linear motifs in nuclear hormone receptors.

Authors:  Ran Xue; Mikhail N Zakharov; Yu Xia; Shalender Bhasin; James C Costello; Ravi Jasuja
Journal:  Mol Endocrinol       Date:  2014-03-28

5.  Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor.

Authors:  X Edward Zhou; Kelly M Suino-Powell; Jun Li; Yuanzheng He; Jeffrey P Mackeigan; Karsten Melcher; Eu-Leong Yong; H Eric Xu
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

6.  beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Authors:  Udi Gluschnaider; Guy Hidas; Gady Cojocaru; Vladimir Yutkin; Yinon Ben-Neriah; Eli Pikarsky
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  ARF represses androgen receptor transactivation in prostate cancer.

Authors:  Wenfu Lu; Yingqiu Xie; Yufang Ma; Robert J Matusik; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2013-02-28

8.  Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.

Authors:  Takashi Kawahara; Satoshi Inoue; Eiji Kashiwagi; Jinbo Chen; Hiroki Ide; Taichi Mizushima; Yi Li; Yichun Zheng; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

Review 9.  The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.

Authors:  Sheng-Qiang Yu; Kuo-Pao Lai; Shu-Jie Xia; Hong-Chiang Chang; Chawnshang Chang; Shuyuan Yeh
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

Review 10.  Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression.

Authors:  Bin Zheng; Mei Han; Michel Bernier; Jin-kun Wen
Journal:  FEBS J       Date:  2009-05       Impact factor: 5.542
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.